Stroke Trial, Recruiting NCT07172789 Sponsor: General Hospital of Shenyang Military Region Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07172789
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have had a stroke caused by a major blocked blood vessel in the brain, where a procedure to remove the clot is planned within 24 hours of symptoms starting
  • People whose stroke symptoms are rated as moderately severe or worse on a standard stroke severity scale (a score of 6 or higher on the NIHSS)
  • People where the expected wait time between being enrolled in the study and the start of the clot-removal procedure is more than 30 minutes
  • People whose brain scan (CT or MRI) shows a score of 6 or higher on a standard scale used to assess how much brain tissue has already been affected (confirm with trial site)
  • People who were largely independent in daily life before the stroke (a score of 1 or less on a standard disability scale)
  • People who have given written consent to participate, or whose legal representative has done so on their behalf

Who may not be able to join:

  • People whose stroke involves bleeding in the brain, rather than a blocked blood vessel
  • People with serious liver or kidney problems, including those whose liver enzyme or kidney function blood test results are significantly above normal levels, or who are on dialysis
  • People with very high blood pressure at the time of enrolment (top number above 185 mmHg or bottom number above 110 mmHg)
  • People with a heart condition rated as Class II or higher on a standard heart failure scale
  • People who are pregnant, planning to become pregnant, or currently breastfeeding
  • People considered to be at significant risk of inhaling food or fluid into the lungs, for example due to obvious nausea or vomiting
  • People whose life expectancy is estimated to be less than 6 months due to another serious illness
  • People whom the research team considers unsuitable for the trial for other medical reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
General Hospital of Shenyang Military Region
Registry
ClinicalTrials.gov
Start date
2 September 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

early neurologic improvement (ENI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov